Newly activated CD8 + T cells reprogram their metabolism to meet the extraordinary biosynthetic demands of clonal expansion; however, the signals that mediate metabolic reprogramming remain poorly defined. Here we demonstrate an essential role for sterol regulatory element-binding proteins (SREBPs) in the acquisition of effector-cell metabolism. Without SREBP signaling, CD8 + T cells were unable to blast, which resulted in attenuated clonal expansion during viral infection. Mechanistic studies indicated that SREBPs were essential for meeting the heightened lipid requirements of membrane synthesis during blastogenesis. SREBPs were dispensable for homeostatic proliferation, which indicated a context-specific requirement for SREBPs in effector responses. Our studies provide insights into the molecular signals that underlie the metabolic reprogramming of CD8 + T cells during the transition from quiescence to activation.
A hallmark of adaptive immunity is the ability of responding T lymphocytes to undergo extensive clonal expansion to protect the host from invading pathogens. To fulfill the requirements of clonal expansion, activated T cells must acquire distinct metabolic programs that meet heightened metabolic demands. Quiescent, naive T cells rely on mitochondrial oxidative phosphorylation and catabolic metabolism to fulfill the minimal energetic and biosynthetic requirements associated with quiescence and long-term survival. After activation, T lymphocytes rapidly switch their metabolic program to rely predominantly on glycolysis in a process highly analogous to the Warburg effect, first described for tumor cells 1 . Additional changes in intermediary metabolism include heightened flux through the pentose-phosphate pathway and greater reliance on glutaminolysis. The 'preferential' use of glycolytic, pentose-phosphate and glutaminolytic pathways enables rapidly dividing T cells to satisfy the heightened metabolic demands during organelle biogenesis and cellular replication 2, 3 . Accordingly, genetic and pharmacological inhibition of glycolytic, glutaminolytic and lipid-biosynthetic pathways attenuates the survival, cell-cycle progression and effector differentiation of T cells [4] [5] [6] [7] [8] [9] . Despite the importance of metabolic reprogramming for effector cell fate and function, the molecular events that link T cell antigen receptor (TCR) signaling with metabolic reprogramming remain enigmatic.
A key component in the metabolic reprogramming of effector T lymphocytes is rapid upregulation of lipid-biosynthetic pathways 4, 8 .
Early isotopomer-enrichment studies demonstrated that activation of lymphocytes results in a rapid increase in new biosynthesis of cholesterol and fatty acids 4 . Critically, the addition of specific cholesterol derivatives (such as oxysterols) to cultures results in diminished lipid biosynthesis and inhibits cell-cycle progression in G1 phase, which suggests a link between lipid metabolism and cell-cycle progression. Subsequent studies have shown that statins, which are pharmacologic inhibitors of HMG-CoA reductase (the rate-limiting enzyme in cholesterol biosynthesis), also inhibit mitogen-driven lymphocyte population expansion 10 . Moreover, it has been established that genetic and pharmacologic perturbations in sterol homeostasis, through the action of the liver X receptor transcriptional axis, also influence the cell-cycle progression, survival and effector function of T lymphocytes 8, 11 . Thus, the regulation of intracellular lipid metabolism is critical for proper lymphocyte growth and function. However, the A r t i c l e s molecular mechanisms that link mitogenic signaling to the lipidanabolic program of activated lymphocytes remain poorly defined.
The sterol regulatory element-binding proteins SREBP1 and SREBP2 are basic helix-loop-helix-zip transcription factors with a well-defined role in the regulation of cellular lipid homeostasis 12 . Mammals have two SREBP-encoding genes that express three SREBPs: SREBP1a and SREBP1c are produced via alternative transcriptional start sites in Srebf1, whereas Srebf2 encodes SREBP2. Canonical SREBP1c signaling 'preferentially' drives the expression of genes encoding molecules involved in the biosynthesis of fatty acids, whereas SREBP2 predominately transactivates genes encoding molecules involved in cholesterol biosynthesis, intracellular lipid movement and lipoprotein import. The SREBP1a isoform is able to transactivate genes that are targets of both SREBP1c and SREBP2. In addition to their function in regulating the expression of genes encoding molecules involved in lipid biosynthesis and transport, SREBPs also transactivate key genes encoding molecules involved in the oxidative pentose-phosphate pathway and generation of the coenzyme NADPH 13 , which ensures the availability of sufficient reducing equivalents to meet anabolic demands.
The influence of SREBP signaling on the metabolism and function of T cells is not well understood. Here we use genetic and pharmacological models to demonstrate that SREBPs were essential for CD8 + T cells to undergo metabolic reprogramming in response to mitogenic signaling. Loss of SREBP function in CD8 + T cells rendered them unable to efficiently blast, which resulted in diminished proliferative capacity in vitro and attenuated clonal expansion during viral infection. SREBP activity was required for the upregulation of glycolytic and oxidative metabolism after activation and for the maintenance of lipid content sufficient to permit rapid membrane biogenesis and cellular growth. We traced the defect in growth and proliferation to a deficiency in cellular cholesterol during blastogenesis, which was restored by cholesterol supplementation. However, SREBPs were dispensable for homeostatic proliferation, which indicated a specific requirement for SREBP signaling to meet the substantial anabolic demands that support effector responses. Our study provides mechanistic insights into the metabolic networks that ensure the growth of effector CD8 + T cells after activation and highlights the importance of SREBPs in regulating a cholesterol metabolic checkpoint during blastogenesis.
RESULTS
The TCR induces a lipid-biosynthesis program T cells rapidly upregulate a program for the biosynthesis of fatty acids and cholesterol after stimulation with polyclonal mitogens 4 . To understand the relationship between mitogenic stimulation and induction of the lipogenic program, we activated purified mouse T cells for 6 h with plate-bound antibody to CD3 (anti-CD3) alone or in combination with anti-CD28. Quantitative RT-PCR analysis showed that anti-CD3 alone was sufficient for the induction of genes encoding molecules involved in cholesterol biosynthesis (Hmgcr, Hmgcs and Sqle) and the biosynthesis of fatty acids (Acaca and Fasn), and the addition of anti-CD28 did not provide additional induction of the program (Fig. 1a) . Activation of Pmel CD8 + T cells (which have transgenic expression of a TCR specific for the melanocytedifferentiation antigen gp100) with increasing doses of agonist gp100 peptide confirmed the requirement for TCR signaling and showed that induction of the lipogenic program occurred at submitogenic doses of antigen ( Supplementary Fig. 1a ). Activation of T cells with the phorbol ester PMA induced the lipogenic program to amounts similar to those achieved by crosslinking of the TCR (Fig. 1a) .
Induction was inhibited by pretreatment of cells with Gö6983, an inhibitor of protein kinase C ( Supplementary Fig. 1b) , which suggested a dependence on protein kinase C. In contrast, culture of cells with the calcium ionophore ionomycin alone did not induce genes encoding molecules involved in lipogenesis ( Fig. 1a ). Together these data indicated that signaling via the TCR and activation of protein kinase C were necessary and sufficient for induction of the lipogenic program in mitogen-stimulated T cells.
Published studies have indicated that loss of Tsc1, a negative regulator of signaling via the kinase mTOR, results in the upregulation of genes encoding molecules involved in sterol biosynthesis and propanoate metabolism in naive CD4 + T cells 14 . Thus, we sought to determine if induction of lipid-biosynthesis programs by mitogens was dependent on mTOR signaling. To address this, we pretreated purified splenic T cells for 30 min with 100 nM rapamycin (an inhibitor of mTOR) or vehicle and then stimulated the cells for up to 6 h with anti-CD3 and anti-CD28. As expected, activation of T cells robustly induced genes encoding molecules involved in the biosynthesis of fatty acids and cholesterol, whereas pretreatment of cultures for 30 min with rapamycin completely inhibited induction of the lipogenic program ( Fig. 1b) . Immunoblot analysis of whole-cell and nuclear extracts showed that rapamycin prevented the processing of fulllength SREBP, which resulted in no accumulation of mature SREBP in the nucleus (Supplementary Fig. 1c ). Inactivation of the phosphatidylinositol-3-OH kinase (PI(3)K) pathway by treatment with LY294002 similarly repressed genes encoding molecules involved in lipogenesis ( Fig. 1b) . These data indicated that signaling through the PI(3)K-mTOR pathway was necessary for the induction of genes encoding molecules involved in the lipid-anabolic program of activated lymphocytes.
SREBPs mediate the lipid-anabolic program of T cells
To directly address the function of SREBPs in induction of the lipogenic program by mitogenic signals, we retrovirally transduced purified splenic and lymph node T cells with a truncated, constitutively active form of SREBP1a (∆SREBP1a) or SREBP2 (∆SREBP2; Supplementary Fig. 1d,e ). We collected mRNA 24 h after retroviral infection and assessed expression of genes encoding molecules involved in lipid biosynthesis by RT-PCR. Cells infected to express ∆SREBP1a or ∆SREBP2 had much higher expression of genes encoding molecules involved in the biosynthesis of fatty acids and cholesterol than did control cells infected with retrovirus containing empty vector ( Fig. 1c) , which indicated that the lipogenic program of T cells was responsive to SREBP signaling.
In complementary experiments, we sought to determine if SREBPs were required for induction of the lipogenic program by mitogenic signaling. To directly address this, we transiently transfected purified mouse spleen and lymph node T cells with small interfering RNA (siRNA) targeting SREBP1 and/or SREBP2 and then stimulated the cells with PMA and ionomycin. After 5 h of stimulation, we collected mRNA and assessed expression of genes encoding molecules involved in lipid biosynthesis. Activation of cells transfected with control siRNA resulted in higher expression of genes encoding molecules involved in new lipid biosynthesis ( Fig. 1d) . In contrast, cells transfected with siRNA targeting SREBP2 were unable to upregulate genes encoding molecules involved in cholesterol synthesis ( Fig. 1d and Supplementary Fig. 1f ). Upregulation of genes encoding molecules involved in the biosynthesis of fatty acids was also inhibited through the use of siRNA targeting SREBP2, albeit to a lesser extent than was the upregulation of genes encoding molecules involved in the biosynthesis of cholesterol ( Fig. 1d) .
A r t i c l e s
We were able to achieve only partial knockdown of SREBP1 with siRNA targeting SREBP1 (Supplementary Fig. 1f ) and, correspondingly, we observed a small effect on genes encoding molecules involved in the synthesis of cholesterol and fatty acids (Fig. 1d) . The observation that overexpression of ∆SREBP1a or ∆SREBP2 resulted in upregulation of genes encoding molecules involved in the biosynthesis of fatty acids and cholesterol in activated T cells led us to hypothesize that SREBP1 and SREBP2 might act together, or share occupancy, at the promoters of genes encoding molecules involved in lipogenesis. Thus, we analyzed lysates of quiescent and activated T cells by chromatin immunoprecipitation (ChIP) of SREBP1 and SREBP2. In quiescent cells, SREBP2 was readily detectable at the promoters of Hmgcr and Hmgcs, which are canonical target genes of SREBP2 ( Fig. 1e) . Activation of T cells for 4 h with PMA resulted in tenfold or greater enrichment in SREBP2 at the promoters of Hmgcr and Hmgcs (Fig. 1e) . Enrichment of SREBP1 was also detectable at the promoters of Hmgcr and Hmgcs. Likewise, we found both SREBP1 and SREBP2 at the promoters of genes encoding molecules involved in the synthesis of fatty acids (Fig. 1e) . These data suggested that both SREBP1 and SREBP2 may have acted together in driving the lipogenic program of activated T cells. Pretreatment of cultures with 10 µM 25-hydroxycholesterol, a well-described sterol inhibitor of SREBP processing, resulted in much less enrichment of SREBP1 and SREBP2 at the promoters of genes encoding molecules involved in lipogenesis ( Fig. 1e ) and, consequently, induction of the lipid-synthesis program ( Supplementary Fig. 1g ). Finally, pretreatment of cultures with 100 nM rapamycin also diminished the enrichment for SREBP1 and SREBP2 to background ( Fig. 1e) , which further indicated that mTOR was needed to link TCR signaling with induction of the lipidsynthesis program via SREBP.
Deletion of the chaperone SCAP inhibits SREBP activity in T cells
Published studies of SREBPs indicate that SREBP1 and SREBP2 can compensate for each other when one protein is deleted 15, 16 . Moreover, our overexpression and ChIP studies suggested that both SREBP1 and SREBP2 could potentially influence the lipid-biosynthesis program in mitogen-stimulated T cells. Thus, we reasoned that loss of both SREBP1 and SREBP2 would be required for full ablation of the lipogenic program of activated T cells. To achieve this, we crossed mice with loxP-flanked alleles encoding the SREBP chaperone protein SCAP ('SREBP cleavage-activating protein'; Scap fl/fl mice) with mice expressing Cre recombinase under control of the Cd4 gene (Cd4-Cre mice) Ex vivo siCtrl siSREBP1 siSREBP2 siSREBP1+2 Figure 1 The lipid-biosynthesis program of activated T cells is SREBP dependent and sensitive to the PI(3)K-mTOR pathway. (a) Real-time PCR analysis of genes encoding molecules involved in lipogenesis in mouse spleen and lymph node T cells activated for 6 h with plate-bound anti-CD3 alone (CD3) or with anti-CD28 (CD3 + CD28), or with PMA or ionomycin (Iono) alone or together (PMA + iono); results are presented relative to those of cells analyzed immediately after isolation (Ex vivo), set as 1. *P < 0.05 and **P < 0.01 (two-tailed unpaired Student's t-test). (b) Real-time PCR analysis of gene expression in T cells pretreated for 30 min with vehicle, the PI(3)K inhibitor LY294002 (Ly294; 10 µM) or the mTOR inhibitor rapamycin (Rap; 100 nM), then activated for 6 h with anti-CD3 and anti-CD28; results are presented relative to those of quiescent T cells (Ex vivo), set as 1. *P < 0.05, LY294002 versus vehicle, †P < 0.05, rapamycin versus vehicle, **P < 0.01, LY294002 versus vehicle, and † †P < 0.01, rapamycin versus vehicle (two-tailed unpaired Student's t-test). (c) Real-time PCR analysis of genes encoding molecules involved in lipogenesis in activated T cells transduced for 24 h with active SREBP (∆SREBP1a or ∆SREBP2) or empty vector (EV); results are presented relative to those of uninfected T cells (UI), set as 1. *P < 0.05, empty vector versus ∆SREBP1a, †P < 0.05, empty vector versus ∆SREBP2, **P < 0.01, empty vector versus ∆SREBP1a, and † †P < 0.01, empty vector versus ∆SREBP2 (two-tailed unpaired Student's t-test). (d) Real-time PCR analysis of gene expression in T cells transfected with siRNA targeting SREBP1 alone (siSREBP1) or siSREBP2 alone (siSREBP2), or both together (siSREBP1+2) or nontargeting control siRNA (siCtrl), then activated for 5 h with PMA and ionomycin; results are presented relative to those of quiescent T cells (Ex vivo), set as 1. *P < 0.05, siCtrl versus siSREBP1, †P < 0.05, siCtrl versus siSREBP2, † †P < 0.01, siCtrl versus siSREBP2, § § P < 0.01, siCtrl versus siSREBP1+2, † † †P < 0.001, siCtrl versus siSREBP2, and § § § P < 0.001, siCtrl versus siSREBP1+2 (two-tailed unpaired Student's t-test). (e) ChIP analysis of the abundance of SREBP1 and SREBP2 at the promoters of various genes (vertical axes) in splenocytes immediately after isolation (Ex vivo) or splenocytes pretreated for 30 min with vehicle, rapamycin (100 nM) or 25-hydroxycholesterol (25-HC; 10 µM) and then activated for 4 h with PMA; results are normalized to input and are presented relative to those obtained with immunoglobulin G (IgG). Rplp0, control gene not targeted by SREBPs. Inset, immunoblot analysis of phosphorylated (p-) and total S6 in whole-cell lysates of cells treated as in graphs (to confirm rapamycin function). *P < 0.05, vehicle versus rapamycin, †P < 0.05, vehicle versus 25-HC, **P < 0.01, vehicle versus rapamycin, † †P < 0.0.01, vehicle versus 25-HC, ***P < 0.001, vehicle versus rapamycin, and † † †P < 0.001, vehicle versus 25-HC (two-tailed unpaired Student's t-test). Data are representative of at least three experiments (mean and s.d. of triplicates).
A r t i c l e s to achieve T cell-specific deletion of Scap in the Scap fl/fl Cd4-Cre progeny (called 'Scap fl/fl ' here). SCAP is associated with SREBPs in the endoplasmic reticulum (ER) membrane and regulates the processing and subsequent transcriptional activity of both SREBP1 and SREBP2 (ref. 17) . We found no difference between 5-to 6-week-old Scap fl/fl mice and their Scap +/+ Cd4-Cre littermates (called 'wild-type mice' here) in the cellularity of thymus, spleen and lymph node ( Fig. 2a) . Phenotypic analysis of thymic and peripheral T cell subsets demonstrated no demonstrable difference between Scap fl/fl and wild-type mice in the frequency of CD4 + or CD8 + T cells ( Fig. 2b) . We also did not find a difference between these mice in the expression pattern of the activation markers CD25 and CD44 ( Supplementary  Fig. 2a ) or in the total number of CD4 + CD25 + and CD8 + CD44 + cells (Supplementary Fig. 2b ). Finally, we did pulse-chase experiments with the thymidine analog BrdU to monitor the homeostatic maintenance of peripheral T cells and found no substantial difference between these mice in labeling or decay over a 42-day period ( Supplementary Fig. 2c) .
Gene-expression studies confirmed nearly complete deletion of Scap in quiescent peripheral Scap fl/fl T cells, and we observed a modest change in the expression of genes encoding molecules involved in lipogenesis ( Fig. 2c) . ChIP studies demonstrated that T cell-specific deletion of Scap resulted in a slightly lower abundance of detectable SREBP protein at the promoters of target genes in quiescent cells (Fig. 2d) . As expected, wild-type cells rapidly upregulated the lipid-biosynthesis program after activation ( Fig. 2c) , which led to more SREBP1 and SREBP2 at the promoters of target genes (Fig. 2d) . In contrast, the induction of genes encoding molecules involved in lipogenesis was considerably attenuated in Scap fl/fl CD8 + T cells ( Fig. 2c) . Correspondingly, we observed a significantly lower abundance of SREBP1 and SREBP2 at promoters of genes encoding molecules involved in lipid biosynthesis ( Fig. 2d ). Together these data indicated that the SREBP-dependent lipid-biosynthesis program was largely dispensable for quiescent peripheral T cells; however, genetic deletion of Scap attenuated upregulation of the SREBP transcriptome of mitogenstimulated T cells.
SREBPs influence CD8 + T cell growth and proliferation
To determine if loss of SREBP activity would influence T cell blastogenesis and proliferation in vitro, we labeled purified wild-type and Scap fl/fl CD8 + T cells with the cytosolic dye CFSE, then stimulated the cells for 72 h with anti-CD3 with or without anti-CD28 or IL-2.
Wild-type T cells enlarged by 24 h ( Fig. 3a and Supplementary  Fig. 3a ) and diluted CFSE by 72 h after activation with mitogens ( Fig. 3b) . In contrast, Scap fl/fl CD8 + T cells did not undergo substantial enlargement ( Fig. 3a and Supplementary Fig. 3a ) and proliferated only modestly in response to anti-CD3 (Fig. 3b ). The addition of exogenous IL-2 and/or anti-CD28, or PMA and ionomycin, to cultures resulted in only slightly greater proliferation of Scap fl/fl T cells ( Fig. 3b) . Cell-cycle analysis indicated that activated Scap fl/fl CD8 + T cells remained in the G0-G1 phases of the cell cycle (Fig. 3c) . The addition of anti-CD28 and/or IL-2 to cultures resulted in a slightly greater proportion of cells in the S and G2-M phases (Fig. 3c) . These data indicated that SREBP signaling was essential for mitogen-driven blastogenesis, proliferation and survival of CD8 + T cells.
Our cell-cycle data indicated that Scap-deficient T cells remained in the G0-G1 phases. To better define whether Scap-deficient T cells were able to move out of the G0 phase into the G1 phase of the cell cycle, we assessed expression of G1 phase-associated cyclins and restriction-point proteins. Immunoblot analysis of wild-type and Scap fl/fl CD8 + T cells activated for 18 h indicated that Scap fl/fl T cells upregulated cyclin D2 and cyclin D3 (Fig. 3d) . We also observed less phosphorylation of the cell-cycle-checkpoint protein Rb and maintenance of the cell-cycle inhibitor p27 Kip (Fig. 3d) , which suggested that Scap fl/fl cells were moving into the G1 phase of the cell cycle but were not entering S phase. We also determined if the loss of SREBP activity resulted in apoptosis. However, kinetic studies indicated no difference between wild-type and Scap fl/fl cells in the frequency of cells positive for cleaved caspase-3 up to 36 h after activation ( Fig. 3e) . Similarly, we observed no difference between wild-type and Scap fl/fl cells in the frequency of annexin V-positive CD8 + T cells (data not shown). However, we did observe a substantially lower frequency of Scap fl/fl cells than wild-type cells that were negative for the DNA-intercalating dye DAPI by 48 h (Supplementary Fig. 3b ), which suggested that loss of SREBP activity resulted in non-apoptotic death late in cultures. Together these data indicated that Scap-deficient T cells moved efficiently into the G1 phase of the cell cycle but were unable to exit this phase before undergoing caspase-independent death.
Loss of SREBPs affects the lipid homeostasis of T cells
Next we sought to determine if genetic ablation of SREBP activity grossly perturbed lipid homeostasis in T cells. To address this, we purified splenic T cells from 5-to 8-week-old Scap fl/fl mice and their wild-type littermates. We measured the total content of cholesterol and fatty acids (myristate, palmitate and stearate) by gas chromatographymass spectrometry immediately after isolation. T cells from Scap fl/fl mice had approximately 50% less cellular cholesterol than did T cells from their wild-type littermates (Fig. 4a) . Quiescent Scap fl/fl T cells also had slightly less palmitate than did their wild-type counterparts ( Fig. 4b) ; however, we observed no significant difference between resting wild-type and Scap fl/fl T cells in myristate or stearate. Activation of wild-type T cells for 24 h with anti-CD3 and anti-28 resulted in more cholesterol, myristate, palmitate and stearate on a per-cell basis than that in freshly isolated cells (Fig. 4a,b ). In contrast, Scap fl/fl T cells did not increase their abundance of cholesterol, myristate, palmitate or stearate in response to activation (Fig. 4a,b ).
Together these data indicated that SREBP signaling was required for defining a lipid-homeostasis set point in quiescent T cells and had an essential role in meeting the greater lipid-biosynthesis demands of blastogenesis.
Loss of SREBP does not perturb proximal TCR signals
Given the importance of cholesterol in plasma-membrane fluidity 18 , lipid-raft formation and TCR signaling 19 , we considered the possibility that the diminished proliferative ability and survival of Scap fl/fl CD8 + T cells was a function of altered proximal signaling. To address this, we stimulated T cells for 60 min with anti-CD3 and probed wholecell lysates for phosphorylation of the upstream signaling molecules Zap70, Lck, Lat and p44-p42 (mitogen-activated protein kinases). Regardless of genotype, we observed normal induction of phosphorylation as early as 5 min after stimulation, and this was maintained for as long as 60 min (Fig. 4c) . We also considered the possibility of alterations in the PI(3)K-kinase Akt pathway, given the importance of lipids (such as myristate) in the proper activation of this pathway. However, we did not observe any difference between wild-type and Scap fl/fl cells in phosphorylation of Akt and its downstream target S6 in response to activation (Fig. 4d) . Moreover, activation with PMA and ionomycin, which obviates the requirement for signaling via the TCR and costimulation, did not provide substantial restoration of the cell-cycle progression, viability and proliferative ability of Scap fl/fl T cells (Fig. 3b,c) . These data suggested that it was unlikely that the inability of Scap-deficient T cells to grow was a function of changes in signaling via the TCR and coreceptors.
SREBPs regulate a gene program required for T cell growth
To better understand how SREBP was influencing CD8 + T cell growth and survival, we did global gene-expression studies of quiescent CD8 + T cells and CD8 + T cells stimulated for 6 h with anti-CD3 and anti-CD28. Many genes were either upregulated or downregulated in wild-type CD8 + T cells after stimulation with anti-CD3 and anti-CD28 ( Fig. 5) . Notably, we observed a very similar pattern of gene expression in activated Scap fl/fl cells, which indicated that loss of SREBP activity did not globally perturb T cell activation. Pathway analysis of genes with a significant difference in expression in quiescent wildtype CD8 + T cells relative to their expression in Scap fl/fl CD8 + T cells identified a small set of genes encoding molecules involved in cellular survival that were downregulated in the absence of SREBP activity (P < 0.001; Supplementary Table 1 ).
Next we did pathway analysis of genes with significantly less induction in Scap fl/fl CD8 + T cells than in wild-type cells after activation with anti-CD3 and anti-CD28 through the use of the DAVID bioinformatics database (Database for Annotation, Visualization and Integrated Discovery) 20, 21 . This analysis showed that activated Scap fl/fl npg A r t i c l e s T cells had significantly lower expression of genes encoding molecules functionally related to sterol metabolism and biosynthesis than did their activated wild-type counterparts (P < 0.001; Fig. 5 , Table 1 and Supplementary Table 1 ). Other gene-ontology clusters similarly affected included pathways associated with RNA homeostasis (for example, RNA processing, ribosome biogenesis and rRNA metabolic processes), nuclear and organelle lumen, and nucleolus biogenesis ( Table 1) . Analysis of predicted transcription factors that could mediate the difference between activated wild-type and Scap fl/fl CD8 + T lymphocytes in gene expression showed a significant likelihood that SREBP1 and SREBP2 were involved ( Table 2) . These data further confirmed the idea that loss of SCAP protein negatively influenced SREBP transcriptional gene program during T cell blastogenesis. This analysis also indicated that the transcriptional regulators CREBBP, NFY and YY1 were involved in the expression of genes affected by Scap deficiency ( Table 2) . Given that CREBBP, NFY and YY1 have well-positioned roles in the transcriptional regulation of lipid metabolism, this analysis probably reflected the loss of the lipid-anabolic program in Scap-deficient T cells. Together these data indicated that SREBP signaling specifically regulated a gene program necessary for lipid anabolism and growth of T cells but did not grossly influence T cell activation.
Metabolic reprogramming requires SREBP
To further investigate the metabolic state of Scap-deficient T cells, we analyzed the cellular bioenergetics of quiescent and mitogenstimulated T cells. We observed no difference between quiescent wildtype and Scap fl/fl CD8 + T cells in their basal extracellular acidification rate (ECAR) or oxygen-consumption rate (OCR; Fig. 6a ). Stimulation of wild-type CD8 + T cells for 24 h with anti-CD3 and anti-CD28 resulted in a tenfold greater ECAR and a fourfold greater OCR. In contrast, Scap fl/fl CD8 + T cells stimulated similarly had only a slightly greater OCR and ECAR and were unable to achieve the rates in wild-type cells. Next we directly assessed mitochondrial function (ATP production and spare respiratory capacity) in Scap-deficient CD8 + T cells by monitoring the OCR in response to sequential treatment with the ATPase inhibitor oligomycin, the uncoupling agent FCCP and the electron-transport-chain inhibitors rotenone and myxothiazol (Fig. 6b) . We observed no difference between freshly isolated wildtype and Scap fl/fl CD8 + T cells in basal respiration, ATP production or spare respiratory capacity in response to treatment with oligomycin, FCCP and rotenone-myxothiazol ( Fig. 6c) . Activation of wild-type CD8 + T cells for 24 h with anti-CD3 and anti-CD28 resulted in higher basal OCR than that in quiescent CD8 + T cells (Fig. 6a,c) . Treatment of activated wild-type CD8 + T cells with oligomycin, FCCP and rotenone-myxothiazol also demonstrated greater mitochondrial ATPproduction capacity and spare respiratory capacity in those cells than in their quiescent counterparts (Fig. 6c) , consistent with enhanced mitochondrial function in 'blasting' CD8 + T cells. In contrast, Scap fl/fl CD8 + T cells activated similarly had substantial deficiencies in basal respiration (Fig. 6a,c) , ATP production and spare respiratory capacity after the same treatment (Fig. 6c) , which suggested profound respiratory defects. We considered the possibility that the lower respiratory capacity was a function of perturbations in mitochondrial mass; however, we observed no difference between wild-type and Scapdeficient CD8 + T cells in staining with a dye that targets mitochondria (Fig. 6d) . Together these data suggested that SREBP signaling was required for the acquisition of glycolytic metabolism and heightened mitochondrial respiration during CD8 + blastogenesis.
Glucose and glutamine are important carbon sources for energetics, anaplerosis (replenishment of intermediates in the tricarboxylic acid (Krebs) cycle) and macromolecular biosynthesis in activated lymphocytes 7 . Thus, we sought to determine if SREBP signaling influenced the use of glucose and glutamine in blasting T cells by npg directly measuring the concentration of glucose, glutamine and lactate in culture medium 24 h after activation of wild-type and Scap fl/fl CD8 + T cells with anti-CD3 and anti-CD28. Consistent with our ECAR data, we observed significantly less production of lactate by activated Scap fl/fl CD8 + T cells than by their wild-type counterparts (Fig. 6e) . We also observed correspondingly less consumption of glucose and glutamine in activated Scap fl/fl CD8 + T cells than in their wild-type counterparts (Fig. 6e) . Kinetic analysis of the uptake of 18 F-labeled FDG (2-deoxy-2-( 18 F)fluoro-D-glucose; an 18 F-labeled glucose derivative) by CD8 + T cells showed that both wild-type and Scap fl/fl CD8 + T cells initially increased their glucose uptake in response to activation (Fig. 6f) . In contrast to wild-type CD8 + T cells, Scap fl/fl CD8 + T cells were unable to further increase their glucose uptake beyond 10 h (Fig. 6f) .
RT-PCR analysis showed that Scap fl/fl CD8 + T cells had much lower expression of genes encoding molecules involved in glycolysis (Supplementary Fig. 4a ). Both c-Myc and HIF-1α have important roles in upregulating the glycolytic program 22 ; thus, we considered the possibility that Scap-deficient T cells might have perturbations in those pathways. However, immunoblot analysis indicated normal upregulation of c-Myc expression and more stabilization of HIF-1α in activated Scap fl/fl CD8 + T cells than in their wild-type counterparts (Supplementary Fig. 4b) . Thus, the inability of Scap fl/fl CD8 + T cells to acquire a glycolytic program during activation was probably not a direct function of altered signaling via c-Myc or HIF-1α.
A logical prediction of our metabolic studies was that blasting Scapdeficient T cells would have altered bioenergetics. To directly address this, we measured intracellular ATP concentrations in quiescent CD8 + T cells and CD8 + T cells activated with anti-CD3 and anti-CD28. We observed no difference between wild-type and Scap fl/fl CD8 + T cells in ATP concentration immediately after isolation (Fig. 6g) . Activation of wild-type CD8 + T cells resulted in a slightly greater abundance of ATP by 6 h and fourfold more by 24 h (Fig. 6g) . In contrast, Scap fl/fl CD8 + T cells did not have a greater cellular ATP abundance at 6 h and achieved only twofold more ATP at 24 h after stimulation than that in their unactivated counterparts (Fig. 6g) . We considered the possibility that perturbations in the concentration of ATP would activate the AMP-activated protein kinase (AMPK) pathway in Scap-deficient CD8 + T cells. Consistent with published studies 23 , activation of wildtype T cells resulted in phosphorylation of AMPK and the AMPK target acetyl-CoA carboxylase (Supplementary Fig. 4c ). We noted no difference between similarly activated Scap fl/fl T cells and wild-type CD8 + T cells in their phosphorylation of AMPK and acetyl-CoA carboxylase ( Supplementary Fig. 4c) , which suggested that the difference between wild-type and Scap fl/fl CD8 + T cells in glycolysis and cellular growth was not a function of exaggerated AMPK signaling. Together these data supported the idea that SREBP signaling influenced cellular bioenergetics during blastogenesis independently of the c-Myc, HIF-1α and AMPK pathways.
Cholesterol restores growth of Scap-deficient T cell
Our gene-expression data indicated that loss of Scap influenced mainly lipid homeostasis, in particular flux through the mevalonate pathway. In addition to cholesterol synthesis, the mevalonate pathway is responsible for the generation of nonsteroidal lipid modification of proteins, such as prenylation of the GTPase Ras 8, 24 . Thus, we sought to determine if the addition of excess mevalonic acid to cultures would increase flux into isoprenoid synthesis and restore the growth of Scapdeficient T cells. However, the addition of mevalonic acid (50-100 µM) did not affect survival or blastogenesis (Supplementary Fig. 5a) , which suggested that a defect in the prenylation of proteins could not mechanistically explain the phenotype of Scap fl/fl CD8 + T cells.
Those data led us instead to posit that cholesterol was limiting in Scap fl/fl CD8 + T cells. To directly assess our hypothesis, we activated wild-type and Scap fl/fl CD8 + T cells with anti-CD3 and anti-CD28 in complete medium supplemented with 5 µg/ml of cholesterol conjugated to methyl-β-cyclodextrin. Analysis of cultures up to 48 h showed that the addition of cholesterol to wild-type CD8 + T cells afforded a modest improvement in cellular survival, with no influence on cell size Pathway-enrichment analysis of genes induced less in Scap fl/fl CD8 + T cells activated for 6 h with anti-CD3 and anti-CD28 than in their wild-type counterparts, assessed with the DAVID database and presented as total genes meeting that criterion in each pathway (Count), along with P values (right). Scores in parentheses indicate the overall enrichment score calculated with the EASE score (modified Fisher's exact P value) of each term member (according to the DAVID database). Data are representative of one experiment. Predicted transcription factors negatively regulated in Scap-deficient T cells for the list of genes induced less in Scap fl/fl CD8 + T cells activated for 6 h with anti-CD3 and anti-CD28 than in their wild-type counterparts. P values, Fisher's test; FDR, false-discovery rate. Data are representative of one experiment.
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A r t i c l e s ( Fig. 7a and Supplementary Fig. 5b) . In contrast, Scap fl/fl CD8 + T cells doubled their survival at 48 h, from 21% to 45%, which approached the survival of control T cells without supplemental cholesterol (54%). Furthermore, supplementation with cholesterol restored the cellular enlargement of Scap fl/fl CD8 + T cells after activation with anti-CD3 and anti-CD28 (Fig. 7a,b) . Analysis of the cell cycle at 48 h after stimulation indicated that the addition of cholesterol resulted in a much greater frequency of Scap fl/fl CD8 + T cells in the S and G2-M phases (Fig. 7c) . Likewise, CFSE analysis indicated that Scap fl/fl T cells were now able to undergo robust proliferation in response to mitogenic stimulation (Fig. 7d) . Cellular cholesterol concentrations have been linked to the regulation of phospholipid synthesis. The observation that replenishing cholesterol was sufficient to substantially restore the growth of Scapdeficient T cells led us to investigate whether membrane biogenesis was diminished in the absence of SREBP activity. Membrane biosynthesis occurs in the ER before the membrane is shuttled to other intracellular organelles or the plasma membrane. Thus, we assessed total ER content by flow cytometry in quiescent and newly activated cells through the use of a cell-permeant live-cell stain that is highly selective for the ER. Quiescent Scap fl/fl CD8 + T cells had less ER content than did their wild-type counterparts (Fig. 7e) . Activation of wildtype cells with anti-CD3 and anti-CD28 led to a greater abundance of ER (Fig. 7e) . In contrast, Scap fl/fl CD8 + T cells were deficient in the expansion of the ER during blastogenesis (Fig. 7e) . However, the addition of exogenous cholesterol restored ER growth (Fig. 7f) . These data were consistent with published work linking SREBPs to membrane biogenesis 25 and provided support for the idea that intracellular cholesterol serves as a metabolic checkpoint in cell-cycle progression via regulation of ER-membrane biogenesis.
SREBPs intrinsically regulate virus-specific immunity
To determine if SREBP signaling was also required for efficient T cell clonal expansion in vivo, we challenged wild-type and Scap fl/fl mice with the Armstrong strain of lymphocytic choriomeningitis virus (LCMV). Infection of wild type mice with LCMV Armstrong generates a robust, virus-specific T cell response that leads to rapid control of viral infection within 10-12 d (ref. 26) . On day 8 after infection, we counted splenocytes and stained them with LCMV-specific tetramers of H-2D b and amino acids 33-41 of LCMV glycoprotein (gp33) to assess the abundance of virus-specific CD8 + T cells. Scap fl/fl mice had a much lower frequency and total number of CD8 + T cells specific for H-2D b -gp33 than did wild-type mice (Fig. 8a-c) . We obtained similar results for CD8 + T cells specific for tetramers of H-2D b and amino acids 396-404 of LCMV nucleoprotein (Fig. 8c) , which indicated a globally diminished antiviral T cell response in Scap fl/fl mice. Intracellular staining of interferon-γ and tumor-necrosis factor after challenge with gp33 peptide ex vivo confirmed a lower frequency of responding CD8 + T cells in Scap fl/fl mice than in wild-type mice (Fig. 8d,e) . The LCMV-specific CD8 + T cells generated in Scap fl/fl mice had lower expression of interferon-γ and tumor-necrosis factor than did their wild-type counterparts (Fig. 8d) , which suggested a potential functional defect in the absence of SREBP activity.
Finally, our data indicated an essential requirement for SREBPs in mitogen-driven proliferation in vitro and clonal expansion of viralspecific CD8 + effector cells in vivo. However, we did not observe a significant perturbation in the frequency or absolute number of peripheral T cells from naive Scap fl/fl mice (Fig. 2) . Those data led us to posit that SREBP activity might not be required under homeostatic conditions. To initially address this, we examined the homeostatic proliferation of purified, CFSE-labeled CD8 + T cells adoptively transferred into Thy-1.1 + lymphopenic host mice (deficient in recombinationactivating gene 2 (Rag2 −/− )). On day 6 after adoptive transfer, we assessed the CFSE dilution of donor Thy-1.2 + wild-type or Scap fl/fl T cells from the lymph nodes and spleen of the recipient mice. Consistent with our hypothesis, we observed no difference in the proliferative patterns of wild-type and Scap fl/fl mice T cells (Fig. 8f) . We also observed similar proliferative results in a sublethal-irradiation model of homeostatic proliferation 27 (Fig. 8f) . By RT-PCR analysis, we found that homeostatically proliferating cells did not upregulate the SREBPdriven expression of genes encoding molecules involved in cholesterol synthetisis, although we did observe very modest upregulation of Fasn (Fig. 8g) . Thus, we posited that a chief difference between T cells undergoing homeostatic proliferation and those undergoing conventional antigen-driven proliferation might be cellular growth.
Indeed, analysis of cell size indicated that homeostatically proliferating 
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A r t i c l e s CD8 + T cells from OT-I mice (which have transgenic expression of an ovalbumin-specific TCR) remained small despite undergoing significant proliferation in lymphopenic hosts. In contrast, OT-I CD8 + T cells adoptively transferred into lymphopenic hosts underwent conventional blastogenesis after immunization of the host with ovalbumin ( Fig. 8h ). Together these data demonstrated a context-specific requirement for SREBP signaling during conventional antigen-driven responses to support cellular enlargement and effector function.
DISCUSSION
The molecular events that guide the metabolic reprogramming of T cells during activation remain poorly understood. Our studies have convincingly demonstrated that SREBPs were essential in coordinating TCR signaling with a lipid-anabolic program requisite for rapid membrane biosynthesis and cellular growth. In the absence of SREBP signaling, newly activated CD8 + T cells moved into the G1 phase of the cell cycle but were unable to grow, which resulted in a lower proliferative capacity and considerably attenuated antiviral immune responses. Notably, we traced that defect in growth and proliferation to an insufficiency in cholesterol. Our data support a model in which an intracellular cholesterol pool, probably in the ER (the site of lipid biosynthesis), serves as a metabolic signal that conveys the fitness of blasting T cells. Consequently, the SREBP gene program facilitates the transition of mitogen-stimulated T cells through a critical metabolic checkpoint during blastogenesis. These signals ensure the coordination of cellular metabolism with the cell cycle. Simply put, without sufficient cholesterol, effector T cells are unable to grow in response to conventional antigenic stimulation.
One unexpected result of our study was the finding that SREBP activity was dispensable for the homeostatic proliferation of CD8 + T cells. SREBPs are important in regulating the proliferative capacity and survival of cancer cells 28, 29 , albeit through poorly described and disparate mechanisms. The influence of SREBPs on the proliferation of primary cells is even less well understood. Our studies of conventional, antigen-driven proliferation and antiviral immunity supported the proposal that SREBPs influence rapid cellular growth. Nevertheless, our observation that Scap-deficient T cells had no observable defect in homeostatic proliferation provided evidence of differences in requirements for SREBP signaling during proliferation. Thus, the emerging idea that engagement of the SREBP pathway is universally required for cellular proliferation and survival is probably incorrect. Alternatively, we propose that SREBP signaling is necessary under circumstances in which cells require the rapid addition of biomass rather than proliferation itself.
An interrelated and important idea centers on the observation that effector CD8 + T cells and memory CD8 + T cells use distinct metabolic programs. The generation of effector CD8 + T cells seems to be favored by glycolytic and anabolic programs, whereas the generation of memory T cells is enhanced under heightened oxidative phosphorylation and catabolism 2, 30 . Our metabolic studies indicated that SREBP signaling was required for a CD8 + T cell to fully acquire a glycolytic phenotype. One possibility is that inhibition of SREBPs in responding T cells could result in 'preferential' enrichment for memory at the expense of effector-cell generation. Published studies have indicated that moderate inhibition of mTOR signaling with a low dose of rapamycin favors the generation of memory CD8 + T cells 31, 32 . Other studies have indicated that mTOR signaling controls cellular metabolism through the HIF and SREBP transcription factors 33 , and our data presented here indicated that the SREBP in CD8 + T cells was sensitive to rapamycin during T cell activation. A logical prediction of such studies is that a low dose of rapamycin would favor the development of CD8 + memory cells through its effects on SREBP activity.
Additional studies will be needed to rigorously test that prediction. Nevertheless, our data raise the possibility that the generation of memory cells and effector cells could be uncoupled by manipulation of sterol metabolism. In conclusion, our studies have delineated a role for SREBPs in controlling conventional, antigen-driven clonal expansion but not homeostatic proliferation. These observations could have implications for the development of new therapeutic strategies that target this pathway to control unwanted effector T cell proliferation without perturbing homeostasis or development.
METHODS
Methods and any associated references are available in the online version of the paper.
